Pharmaceutical Regulatory Affairs in Asia Online Training Set for March 3–5, 2027 — Registration Now Open

Evolving Asian pharma regulations are driving demand for expertise in market entry, clinical trials, product registration and lifecycle compliance for innovative drugs and generics.

Dublin, Sept. 11, 2026 (GLOBE NEWSWIRE) -- "Pharmaceutical Regulatory Affairs in Asia (Mar 3rd - Mar 5th, 2027)" has been added to ResearchAndMarkets.com's offering.

Pharmaceutical Regulatory Affairs in Asia will take place online from March 3–5, 2027, delivering a three-day programme focused on the diverse and evolving regulatory requirements across Asian pharmaceutical markets. Running from 09:00 to 16:30 GMT, the training provides regulatory professionals with detailed coverage of key markets including China, India, Korea and the ASEAN region.

Organised by IPI Academy, the programme examines regulatory pathways, market entry requirements, clinical trials where applicable as prerequisites for product registration, Pharmaceutical Maintenance and other essential regulatory considerations. The course places particular emphasis on innovative products while providing extensive reference to generic pharmaceuticals, giving participants a structured view of regulatory affairs across a fast-growing pharmaceutical landscape.

The agenda progresses from an introduction to the Asia region and ASEAN on Day 1, through India and Southeast Asian markets on Day 2, before addressing Taiwan, Korea, Japan and ASEAN Harmonisation on Day 3. Topics include the Philippines, Brunei, China, Hong Kong SAR, Malaysia, Singapore, Thailand, Indonesia, Vietnam, Cambodia and Laos.

The programme provides 18 CPD hours and is intended primarily for Pharmaceutical Regulatory Affairs professionals working with Asian countries, those seeking updates on recent developments and current challenges, and regulatory professionals new to the Asian region. Professionals from Marketing, Logistics, Production and related functions may also Benefit from the programme's overview of Pharmaceutical Regulatory Affairs in Asia.

Why you Should Attend

• Map key Asian markets: Explore China, India, Korea and ASEAN regulatory environments.
• Follow a structured regional agenda: Progress from ASEAN fundamentals to country-specific regulatory considerations.
• Examine ASEAN Harmonisation: Address regional regulatory alignment on Day 3.
• Strengthen regulatory knowledge: Explore regulatory pathways, market entry requirements and Pharmaceutical Maintenance.
• Earn 18 CPD hours: Apply the programme toward continuing professional development.

Featured Speakers

• Mónica Dressler-Meyer;DRA Manager based in Switzerland with extensive regulatory experience across Asia Pacific; former F. Hoffmann-La Roche professional with a Degree in Chemistry and Biochemistry from Basel University.
• Dr Alan Chalmers;Pharmacist with more than 35 years of industrial experience in pharmaceutical regulatory affairs; former Ciba-Geigy/CIBA/ Novartis regulatory leader, consultant to IFPMA and WHO, and accredited by Swissmedic as a Qualified Person.

For more information about this training visit https://www.researchandmarkets.com/r/7mb4b7

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: 
CONTACT: ResearchAndMarkets.com 
         Laura Wood, Senior  Press Manager 
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470 
         For U.S./ CAN Toll Free Call 1-800-526-8630 
         For GMT Office Hours Call +353-1-416-8900